ORGANIGRAM GLOBAL INC (OGI) Fundamental Analysis & Valuation

NASDAQ:OGI • CA68617J1003

Current stock price

1.43 USD
-0.01 (-0.69%)
Last:

This OGI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. OGI Profitability Analysis

1.1 Basic Checks

  • In the past year OGI was profitable.
  • OGI had a negative operating cash flow in the past year.
  • In the past 5 years OGI always reported negative net income.
  • OGI had negative operating cash flow in 4 of the past 5 years.
OGI Yearly Net Income VS EBIT VS OCF VS FCFOGI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M -200M

1.2 Ratios

  • OGI has a better Return On Assets (3.42%) than 82.81% of its industry peers.
  • Looking at the Return On Equity, with a value of 4.92%, OGI belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
ROA 3.42%
ROE 4.92%
ROIC N/A
ROA(3y)-32.94%
ROA(5y)-24.98%
ROE(3y)-37.82%
ROE(5y)-28.71%
ROIC(3y)N/A
ROIC(5y)N/A
OGI Yearly ROA, ROE, ROICOGI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • OGI has a Profit Margin of 6.49%. This is amongst the best in the industry. OGI outperforms 82.81% of its industry peers.
  • The Gross Margin of OGI (8.13%) is comparable to the rest of the industry.
Industry RankSector Rank
OM N/A
PM (TTM) 6.49%
GM 8.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OGI Yearly Profit, Operating, Gross MarginsOGI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. OGI Health Analysis

2.1 Basic Checks

  • OGI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for OGI has been increased compared to 1 year ago.
  • Compared to 5 years ago, OGI has more shares outstanding
  • OGI has a worse debt/assets ratio than last year.
OGI Yearly Shares OutstandingOGI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
OGI Yearly Total Debt VS Total AssetsOGI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of -0.10, we must say that OGI is in the distress zone and has some risk of bankruptcy.
  • OGI has a Altman-Z score (-0.10) which is in line with its industry peers.
  • OGI has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.17, OGI is in line with its industry, outperforming 46.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -0.1
ROIC/WACCN/A
WACC8.08%
OGI Yearly LT Debt VS Equity VS FCFOGI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • OGI has a Current Ratio of 2.73. This indicates that OGI is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.73, OGI is in line with its industry, outperforming 47.92% of the companies in the same industry.
  • OGI has a Quick Ratio of 1.32. This is a normal value and indicates that OGI is financially healthy and should not expect problems in meeting its short term obligations.
  • OGI has a Quick ratio of 1.32. This is in the lower half of the industry: OGI underperforms 69.79% of its industry peers.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 1.32
OGI Yearly Current Assets VS Current LiabilitesOGI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. OGI Growth Analysis

3.1 Past

  • OGI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 118.94%, which is quite impressive.
  • The Revenue has grown by 68.55% in the past year. This is a very strong growth!
  • Measured over the past years, OGI shows a very strong growth in Revenue. The Revenue has been growing by 24.46% on average per year.
EPS 1Y (TTM)118.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%169.31%
Revenue 1Y (TTM)68.55%
Revenue growth 3Y21.14%
Revenue growth 5Y24.46%
Sales Q2Q%48.7%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.72% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 16.43% on average over the next years. This is quite good.
EPS Next Y183.47%
EPS Next 2Y51.05%
EPS Next 3Y37.96%
EPS Next 5Y23.72%
Revenue Next Year22.24%
Revenue Next 2Y18.01%
Revenue Next 3Y12.01%
Revenue Next 5Y16.43%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
OGI Yearly Revenue VS EstimatesOGI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
OGI Yearly EPS VS EstimatesOGI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. OGI Valuation Analysis

4.1 Price/Earnings Ratio

  • OGI is valuated rather expensively with a Price/Earnings ratio of 20.43.
  • Compared to the rest of the industry, the Price/Earnings ratio of OGI indicates a rather cheap valuation: OGI is cheaper than 83.33% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of OGI to the average of the S&P500 Index (26.91), we can say OGI is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 29.04 indicates a quite expensive valuation of OGI.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of OGI indicates a somewhat cheap valuation: OGI is cheaper than 73.44% of the companies listed in the same industry.
  • OGI's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.68.
Industry RankSector Rank
PE 20.43
Fwd PE 29.04
OGI Price Earnings VS Forward Price EarningsOGI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OGI Per share dataOGI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • OGI's earnings are expected to grow with 37.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y51.05%
EPS Next 3Y37.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OGI Dividend Analysis

5.1 Amount

  • OGI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OGI Fundamentals: All Metrics, Ratios and Statistics

ORGANIGRAM GLOBAL INC

NASDAQ:OGI (4/10/2026, 10:23:25 AM)

1.43

-0.01 (-0.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-10
Earnings (Next)05-11
Inst Owners9.06%
Inst Owner Change0%
Ins Owners0.24%
Ins Owner ChangeN/A
Market Cap194.97M
Revenue(TTM)279.99M
Net Income(TTM)18.17M
Analysts77.78
Price Target2.47 (72.73%)
Short Float %3.51%
Short Ratio5.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-513.86%
Min EPS beat(2)-2513.86%
Max EPS beat(2)1486.14%
EPS beat(4)2
Avg EPS beat(4)-68.73%
Min EPS beat(4)-2513.86%
Max EPS beat(4)1486.14%
EPS beat(8)3
Avg EPS beat(8)-105.21%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.72%
Min Revenue beat(2)-14%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)0.89%
Min Revenue beat(4)-14%
Max Revenue beat(4)8.56%
Revenue beat(8)5
Avg Revenue beat(8)-0.51%
Revenue beat(12)6
Avg Revenue beat(12)-2.26%
Revenue beat(16)8
Avg Revenue beat(16)-0.67%
PT rev (1m)0%
PT rev (3m)-2.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-150%
EPS NY rev (1m)0%
EPS NY rev (3m)1665.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE 20.43
Fwd PE 29.04
P/S 0.96
P/FCF N/A
P/OCF N/A
P/B 0.73
P/tB 1
EV/EBITDA N/A
EPS(TTM)0.07
EY4.9%
EPS(NY)0.05
Fwd EY3.44%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS1.48
BVpS1.96
TBVpS1.43
PEG (NY)0.11
PEG (5Y)N/A
Graham Number1.76
Profitability
Industry RankSector Rank
ROA 3.42%
ROE 4.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 6.49%
GM 8.13%
FCFM N/A
ROA(3y)-32.94%
ROA(5y)-24.98%
ROE(3y)-37.82%
ROE(5y)-28.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 89.52%
Cap/Sales 6.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 1.32
Altman-Z -0.1
F-Score4
WACC8.08%
ROIC/WACCN/A
Cap/Depr(3y)85.08%
Cap/Depr(5y)98.16%
Cap/Sales(3y)9.58%
Cap/Sales(5y)15.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)118.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%169.31%
EPS Next Y183.47%
EPS Next 2Y51.05%
EPS Next 3Y37.96%
EPS Next 5Y23.72%
Revenue 1Y (TTM)68.55%
Revenue growth 3Y21.14%
Revenue growth 5Y24.46%
Sales Q2Q%48.7%
Revenue Next Year22.24%
Revenue Next 2Y18.01%
Revenue Next 3Y12.01%
Revenue Next 5Y16.43%
EBIT growth 1Y24.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year246.88%
EBIT Next 3Y67.83%
EBIT Next 5Y45.95%
FCF growth 1Y36.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y43.8%
OCF growth 3YN/A
OCF growth 5YN/A

ORGANIGRAM GLOBAL INC / OGI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ORGANIGRAM GLOBAL INC?

ChartMill assigns a fundamental rating of 4 / 10 to OGI.


Can you provide the valuation status for ORGANIGRAM GLOBAL INC?

ChartMill assigns a valuation rating of 4 / 10 to ORGANIGRAM GLOBAL INC (OGI). This can be considered as Fairly Valued.


How profitable is ORGANIGRAM GLOBAL INC (OGI) stock?

ORGANIGRAM GLOBAL INC (OGI) has a profitability rating of 3 / 10.


Can you provide the financial health for OGI stock?

The financial health rating of ORGANIGRAM GLOBAL INC (OGI) is 3 / 10.